CPT® Code 90620

Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB-4C), 2 dose schedule, for intramuscular use

The CPT® Code 90620 refers to a specific vaccine known as the meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB-4C). This vaccine is designed to prevent infections caused by the bacterium Neisseria meningitidis serogroup B in individuals aged 10 years and older. The N. meningitidis serogroup B bacterium is a significant public health concern as it is prevalent worldwide and can be transmitted through respiratory droplets and oral secretions, such as during activities like coughing, kissing, or sharing food and utensils. Infection with this bacterium can lead to severe health complications, including meningitis, which is an inflammation of the protective membranes covering the brain and spinal cord, and sepsis, a life-threatening condition resulting from the body's response to infection. The consequences of such infections can be dire, potentially resulting in fatalities within hours or days, or leading to long-term disabilities such as hearing loss, brain damage, and limb amputation. The vaccine coded as 90620 is administered intramuscularly and follows a two-dose schedule, with the doses given at least one month apart. It is important to note that this code specifically reports the vaccine supply itself, while the administration of the vaccine is reported separately under different codes. This distinction is crucial for accurate medical coding and billing practices.